56 related articles for article (PubMed ID: 25664626)
1. Baseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Cancer Screening Study.
Yousaf-Khan U; Horeweg N; van der Aalst C; Ten Haaf K; Oudkerk M; de Koning H
J Thorac Oncol; 2015 May; 10(5):747-753. PubMed ID: 25664626
[TBL] [Abstract][Full Text] [Related]
2. Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation.
Goodley P; Balata H; Alonso A; Brockelsby C; Conroy M; Cooper-Moss N; Craig C; Evison M; Hewitt K; Higgins C; Johnson W; Lyons J; Merchant Z; Rowlands A; Sharman A; Sinnott N; Sperrin M; Booton R; Crosbie PAJ
Thorax; 2023 Dec; 79(1):58-67. PubMed ID: 37586744
[TBL] [Abstract][Full Text] [Related]
3. The effect of the introduction of the national lung cancer screening program on short-term mortality in Korea.
Kim W; Lee SC; Lee WR; Chun S
Lung Cancer; 2023 Dec; 186():107412. PubMed ID: 37856923
[TBL] [Abstract][Full Text] [Related]
4. Can non-participants in a follow-up be used to draw conclusions about incidences and prevalences in the full population invited at baseline? An investigation based on the Swedish MDC cohort.
Nilsson A; Björk J; Strömberg U; Bonander C
BMC Med Res Methodol; 2023 Oct; 23(1):228. PubMed ID: 37821822
[TBL] [Abstract][Full Text] [Related]
5. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Lammers JW; van Ooijen P; Nackaerts K; Weenink C; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
Thorax; 2017 Jan; 72(1):48-56. PubMed ID: 27364640
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of the introduction of low-dose CT screening in Japanese smokers aged 55 to 74 years old.
Tabata H; Akita T; Matsuura A; Kaishima T; Matsuoka T; Ohisa M; Awai K; Tanaka J
Hiroshima J Med Sci; 2014 Sep; 63(1-3):13-22. PubMed ID: 25735063
[TBL] [Abstract][Full Text] [Related]
9. Improving selection criteria for lung cancer screening. The potential role of emphysema.
Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
[TBL] [Abstract][Full Text] [Related]
10. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
[TBL] [Abstract][Full Text] [Related]
11. Low-dose computed tomographic screening for lung cancer.
Christensen JD; Chiles C
Clin Chest Med; 2015 Jun; 36(2):147-60, vii. PubMed ID: 26024597
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer screening guidelines: common ground and differences.
Gulati S; Mulshine JL
Transl Lung Cancer Res; 2014 Jun; 3(3):131-8. PubMed ID: 25806292
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated.
Mortani Barbosa EJ
Acad Radiol; 2015 Aug; 22(8):976-82. PubMed ID: 25772581
[TBL] [Abstract][Full Text] [Related]
14. Results of an open-access lung cancer screening program with low-dose computed tomography: the Gdańsk experience.
Rzyman W; Dziedzic R; Jelitto-Górska M; Biadacz I; Książek J; Siebert J; Zdrojewski T; Studniarek M
Pol Arch Med Wewn; 2015; 125(4):232-9. PubMed ID: 25764248
[TBL] [Abstract][Full Text] [Related]
15. Screening for prevention and early diagnosis of cancer.
Wardle J; Robb K; Vernon S; Waller J
Am Psychol; 2015; 70(2):119-33. PubMed ID: 25730719
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer CT screening is cost-effective but implementation matters.
Goulart B
Evid Based Med; 2015 Apr; 20(2):78. PubMed ID: 25715973
[No Abstract] [Full Text] [Related]
17. Lung cancer screening with low dose CT: experience at Campus Bio-Medico of Rome on 1500 patients.
Crucitti P; Gallo IF; Santoro G; Mangiameli G
Minerva Chir; 2015 Dec; 70(6):393-9. PubMed ID: 25700151
[TBL] [Abstract][Full Text] [Related]
18. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
de Koning HJ; van der Aalst CM; de Jong PA; Scholten ET; Nackaerts K; Heuvelmans MA; Lammers JJ; Weenink C; Yousaf-Khan U; Horeweg N; van 't Westeinde S; Prokop M; Mali WP; Mohamed Hoesein FAA; van Ooijen PMA; Aerts JGJV; den Bakker MA; Thunnissen E; Verschakelen J; Vliegenthart R; Walter JE; Ten Haaf K; Groen HJM; Oudkerk M
N Engl J Med; 2020 Feb; 382(6):503-513. PubMed ID: 31995683
[TBL] [Abstract][Full Text] [Related]
19. Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.
Spiro SG; Shah PL; Rintoul RC; George J; Janes S; Callister M; Novelli M; Shaw P; Kocjan G; Griffiths C; Falzon M; Booton R; Magee N; Peake M; Dhillon P; Sridharan K; Nicholson AG; Padley S; Taylor MN; Ahmed A; Allen J; Ngai Y; Chinyanganya N; Ashford-Turner V; Lewis S; Oukrif D; Rabbitts P; Counsell N; Hackshaw A
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31537697
[TBL] [Abstract][Full Text] [Related]
20. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
National Lung Screening Trial Research Team
J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
